Histamine’s Role in Food and Atopic Dermatitis

Histamine: Bridging Food and Atopic Dermatitis

Ayaad Bharti1 and Sanket K. Mishra2

  1. Department of Veterinary Medicine, North Carolina State University, Raleigh, NC, USA
  2. Comparative Medicine Institute, North Carolina State University, Raleigh, NC, USA

OPEN ACCESS

PUBLISHED: 30 NOVEMBER 2024

CITATION: BHARTI, Arya; MISHRA, Santosh K.. Histamine: Bridging Food and Atopic Dermatitis. Medical Research Archives, [S.l.], v. 12, n. 11, dec. 2024. Available at: <https://esmed.org/MRA/mra/article/view/6144>

COPYRIGHT: © 2025 European Society of Medicine. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

DOI: https://doi.org/10.18103/mra.v12i11.6144

ISSN 2375-1924

Abstract

Atopic dermatitis (AD) is an inflammatory skin condition, often characterized by intense itching, rashes in humans and animals, and disruption of skin barriers. The prevalence depends on the patient’s age, ethnic background, and geographical origin. In recent years, the average number of cases in industrialized countries has more than doubled, with the disease impacting around 25% of children and 2% of adults worldwide. People with AD have a higher risk of developing other conditions such as arthritis, asthma, depression, anxiety, allergic rhinitis, and sleep problems that negatively impact the patient’s quality of life. Recent data suggest that increased histamine levels are involved in the pathogenesis of AD. However, a review from Bath-Hextall et al. suggested no correlation between histamine levels and the severity of AD. In this article, we focus on the relationship between histamine, food, and AD in humans and animals.

Keywords

Atopic dermatitis, histamine, food, skin barrier, allergies

Introduction

Atopic dermatitis (AD) is an inflammatory skin condition (often named eczema) that causes itchy rashes in humans and animals.¹ The prevalence of disease depends on the patient’s age, ethnic background, and geographical origin.² In recent years, the average number of cases in industrialized countries has more than doubled, with the disease impacting around 25% of children and 2% of adults worldwide.¹ People with AD have a higher risk of developing other conditions such as arthritis, asthma, depression, anxiety, allergic rhinitis, and sleep problems that negatively impact the patient’s quality of life.³ Recent data suggest that neural recruitment is involved early in activating allergic stimulation of AD and helps maintain the inflammatory cascade.⁴ The exact cause/mechanism of AD is not well understood but several comorbidities, including food allergy, asthma, allergic rhinitis, and mental health disorders can impact AD.

The first part of this review will focus on the relationship between AD and histamine, types of food with histamine, and enzymes responsible for regulation of histamine that might be involved in initiation and aggravation of AD and associated itch. Itch is a major symptom associated with AD and the cellular release of histamine and its role in itch is well-established. Therefore, the second part of the review will focus on itch and its mechanisms as well as discussing the role of histamine receptors that have been linked to AD.


Relationship among histamine or histidine rich food and atopic dermatitis

Foods can significantly trigger AD and food allergies, which have been linked to the disease.⁵ Although food allergies and allergens are not necessarily the direct cause of atopic dermatitis, they can be indirectly involved in the aggravation of the disease. One study in humans shows that ingesting moderate or high amounts of histamine-hydrochloride may aggravate eczema in a subgroup of patients with AD.⁶⁻⁸ Common allergens in AD are mostly high protein foods, cow’s milk, eggs, and fermented foods.⁵⁻⁷⁹ Most of these foods contain the chemical compound histamine that is involved in the aggravation of AD. However, a review from Bath-Hextall et al. suggested no benefit of egg and milk free diet in unselected participants with atopic eczema.¹⁰ The authors also remain open that this may be due to small population size and maybe these individuals are not allergic to these substances in the first place.

Along with an increase of histamine level in plasma, an increase in the level of skin histamine has been reported among patients of acute AD.¹¹ Histamine is a biogenic amine, formed by the action of the enzyme histidine decarboxylase on proteinogenic amino acids, L-histidine. Histamine plays a crucial role in many physiological and pathophysiological processes. Histamine regulates gastric acid secretion in the stomach, acts as a neurotransmitter, and mediates anaphylaxis in allergic conditions.¹² In mammals, histamine is known to be present in all tissues, primarily the skin connective tissue, lung, and most of the gastrointestinal tract.¹³ It is involved in functional execution through primarily four types of histamine receptors that have been identified and characterized; they are H1, H2, H3, and H4 receptors.¹⁴ Excess histamine release in the body either through cellular release or via histamine-rich food¹⁵ can lead to the flare-up of atopic dermatitis.¹⁶¹⁸

Although the link between AD and diet has been unclear for a long time, some connections between AD and food have been proposed based on diet elimination/supplementation that helps to reduce or improve AD conditions in a subgroup of patients.¹⁹ Several reports suggest that histamine and its four receptors are linked to atopic dermatitis and itch.²⁰ Blood plasma histamine levels are higher in AD patients,²¹ and enhanced release has been observed in the skin of AD individuals.²² Their study and others suggest a possible association between high histamine diet and AD.²³²⁴

In an elimination approach, a recent study aimed to investigate the relationship between histamine and atopic dermatitis.²⁵ The study included atopic dermatitis and healthy individuals and was conducted in a hospital setting.

Researchers collected skin biopsies from all participants and analyzed the samples for histamine levels. They used immunohistochemistry methods to determine the amount of histamine in the skin samples. They also recorded the severity of eczema symptoms in each participant, as well as other clinical information such as age, sex, and history of allergies. In addition, in the group of the atopic dermatitis patients, researchers also treated them with an antihistamine (cetirizine) for a period of four weeks, and then re-assessed the histamine levels in the skin and the symptoms of eczema. Participants were given the antihistamine in oral form and at a daily dose of 10 mg.

The results showed that histamine levels were significantly higher in the skin of participants with atopic dermatitis compared to those without the condition. This confirms previous findings that histamine plays a key role in eczema symptoms. Furthermore, the eczema symptoms improved significantly in patients treated with antihistamine. The itching, redness, and inflammation of the skin were all reduced in the group of patients treated with antihistamines.

The study concludes that histamine is involved in the development of the eczema symptoms and that antihistamines may be an effective treatment for atopic dermatitis. The study also highlights the importance of understanding the underlying mechanisms of eczema in order to develop new and more effective treatments. The study is important because it provides more evidence that histamine is involved in the pathology of eczema, and that antihistamines may be effective in reducing symptoms of eczema. The study also provides a rationale for further research in the field, including the development of more specific and targeted antihistamine treatments for eczema.

In another study, a six-year-old boy was admitted to the hospital with severe AD for the evaluation of food as a triggering factor for his skin disease. In a food challenge test, he showed a positive result of exacerbated eczema score for both eczema area and severity index (EASI) score and the visual analog scale (VAS) when he was on 200 g of pork diet compared to eating 60 g of pork. Interestingly, keeping him on a balanced and low-histamine dietary regimen showed improvement in AD symptoms and that lasted for more than seven months. This suggests a low-histamine, balanced diet could be helpful for AD patients, and histamine-rich diet aggravates AD without having any issues of food allergy.

Almost one percent of the human population worldwide is affected by histamine intolerance.²⁷⁻²⁸ Certain lactic acid bacteria with the hdcA (Histidine decarboxylase) gene can convert the amino acid histidine into histamine.²⁹ The main histamine-producing bacterial strains in wine transformation belong to the genera Oenococcus, Lactobacillus, and Pediococcus.²⁹ Analysis of several sample collections from different wineries shows that these bacteria are present in almost all wines at an exceedingly high level. Also, hdcA was detected in most of the unstable plasmids in strains of Oenococcus.³⁰ Therefore, histamine is produced in the body in large amounts due to the food and drinks containing these bacteria that transform histidine into histamine using the enzyme decarboxylase.

Histamine is found in large amounts in many commercial soybean products like tofu, tempeh, tamari, and sufu (fermented soybean), etc. In the case of sufu samples, very high histamine levels (700 mg/kg) were found, which is very unhealthy for a patient. Biogenic amines present in soybean products are not a risk for healthy consumers, but patients who take drugs with monoamine and diamine oxidase inhibitors can suffer adverse health effects by eating such high-histamine foods.³⁰

Several cases of scombroid fish (tuna, mackerel, swordfish, kingfish, etc.) poisoning occur after consuming these fish which are rich in the amino acid histidine.³¹⁻³² Urinary excretion analysis of patients sick with scombroid fish poisoning shows high-level histamine and its metabolite.³²

The primary dietary sources high in histamine are fermented foods, beverages like kefirs, kombucha, yogurt, frozen and smoked fish, and fruits such as strawberries and cherries. Vegetables that are high in histamine are spinach, eggplant, and potato. Chili powder, cinnamon, and cloves are found to be very rich in histamine as well.

Certain foods are not necessarily high in histamine but act as histamine-trigger foods, such as citrus fruits, alcohol, and nuts.²⁷³⁶³⁷ Other common foods such as cheese, blue cheese, and parmesan cheese also have very high histamine. This may not be an issue in healthy individuals with normal histamine-degrading enzyme levels. However, these foods with high histamine can further aggravate symptoms of atopic dermatitis in patients with histamine intolerance (HIT).³⁵³⁸ They are unable to degrade even normal levels of histamine from food, let alone food with higher histamine. This is due to their deficiency in enzymes that help destroy ingested histamine.³⁵

A recent report demonstrated a link between a histamine diet and AD. In this report, 36 patients were placed on a low-histamine diet for one week. Twelve of the 36 patients showed significant improvement in atopic dermatitis after one week of the low-histamine diet intake, which suggests only a small subset of AD patients show a correlation of low-histamine diet and improvement of symptoms in AD patients.³⁹ Briefly, the role of histamine in the maintenance of AD is linked to our daily intake of food, and this might occur in most AD individuals, but the role of types of food described above in the causation of itch is still largely unknown.

In addition to diet, histamine plasma levels did not decrease in AD individuals, suggesting that these large groups react differently and the release of histamine in this group is either due to decreased histamine metabolism or due to continuous release of histamine through IgE-mediated reaction — this is not yet clear.⁴

In mammalian skin, L-histidine is incorporated into filaggrin, which is a skin barrier protein and is linked to AD etiology. To evaluate the therapeutic role of L-histidine in AD patients, the authors conducted a randomized, double-blind, placebo-controlled, crossover, nutritional supplementation pilot study.³⁹ Daily single oral L-histidine administration for 4 weeks significantly reduced AD symptoms by both physician assessment using the SCORing AD tool and patient self-assessment using the Patient Oriented Eczema Measure tool compared to the placebo.

The authors further demonstrated the L-histidine effects on pro-filaggrin processing and skin barrier functions on HaCaT keratinocyte cultures and in organotypic skin-equivalent cultures. On keratinocyte cells, they showed that L-histidine increases filaggrin protein formation, and in the organotypic skin model, they illustrated that L-histidine enhances the barrier function. Both these in vitro observations correlate with evidence from the clinical nutritional pilot study that oral L-histidine may have therapeutic benefits in AD.

In another clinical pilot study by a completely independent group on two different age groups (Adults and Young Children) with AD, the authors showed oral L-histidine is effective for AD management.⁴⁰ A single dose of L-histidine was given to adults (4 g daily) and to young children (0.8 g) supplementation over periods of 4 weeks (adults) or 12 weeks (young children). Compared to the placebo, L-histidine reduced AD in both adult and young children using the SCORing AD tool. The supplementation is well-tolerated and has potential as a safe intervention for long-term use in the management of AD, but some adverse events have been reported, suggesting continuous safety evaluation for long-term usage.


Involvement of histamine regulating enzymes in atopic dermatitis

Histamine intolerance is a condition that can be further aggravated in HIT patients by histamine-rich foods, which either cause histamine release or block the enzyme diamine oxidase.³⁶⁴¹ It can further lead to many disorders of the gastrointestinal system, skin, lungs, cardiovascular system, and brain. Dermatological problems that can arise include rashes, itch, urticaria, dermatitis, psoriasis, and rosacea.³⁶³⁵⁴²

Diamine oxidase is the main enzyme for the metabolism of dietary histamine and is responsible for the catabolism of extracellular histamine, whereas histamine N-methyltransferase (HNMT) is responsible for catabolizing histamine in intracellular spaces of cells.³⁶ Various single-nucleotide polymorphisms (SNPs) show correlations between inflammatory and neoplastic gastrointestinal diseases like food allergy, Crohn’s, and colitis. However, no significant association is seen by investigating HNMT alleles and patients.

with inflammatory and gastrointestinal diseases.³⁶⁴³⁴⁵ On the contrary, some studies show an association between HNMT polymorphisms and AD in children. A study to evaluate the association between HNMT polymorphisms and AD in children concluded that polymorphisms in HNMT appear to confer susceptibility to AD in Korean children.⁴⁶ A study has shown that Thr105Ile, a functional polymorphism of HNMT, is linked with alcoholism in two ethnically distinct populations.⁴⁷ In another study, association of food additives and HNMT T939C and HNMT Thr105Ile gene polymorphisms was established.⁴⁸

In the CNS, histamine acts as a neurotransmitter and has been shown to be involved in reward function and in the etiology of addiction and stress. In the periphery, it is considered as a mediator, but it will be interesting to explore the role of histamine in the CNS in chronic AD conditions.

Structurally, the diamine oxidase (DAO) enzyme with 700 amino acids is proposed to be a dimer of 92 kDa encoded by the AOCT gene.⁴⁹⁵¹ The association of low DAO and increased plasma histamine was shown in atopic eczema.⁵² In a separate study, high histamine amounts in plasma combined with reduced histamine degradation influenced the clinical score in AD.⁵³ Recently, an experiment with 14 patients with allergic conditions like food hypersensitivity, coeliac disease, etc., was investigated for serum DAO level and clinical response to DAO supplementation.

These patients were placed on histamine-rich food. Their results indicate that 10 out of 14 patients had reduced serum DAO activity (<10 U/ml), which suggests probable histamine intolerance. Moreover, 13 out of 14 patients showed significant relief in disturbances related to food intolerances with the intake of DAO supplementation.⁴¹ Measuring DAO activity in serum is useful in determining histamine intolerance.⁴¹

Furthermore, histamine plays a major part in food and wine intolerance, and lack of DAO in AD patients with intolerance to food or wine causes worsening symptoms in atopy.¹⁵

Based on the influence of active ingredients of certain drugs on the activity of human diamine oxidase, many substances can be designated as DAO inhibitors.⁵⁴ Chloroquine and clavulanic acid are such drugs that showed the greatest inhibition potential of up to 90 percent. Other medications like Verapamil have an inhibition rate of almost 50 percent. Drugs like Diclofenac, metoclopramide, suxamethonium, and thiamine have a very low inhibition rate.⁵⁴

A correlation between atopic eczema and decreased DAO activity was observed in patients with high blood serum histamine levels. Their blood DAO activity and histamine concentration were evaluated with a radio extraction radioimmunoassay. Their results showed the presence of wheals, which were 35 percent larger in diameter in almost 47% of patients. These patients had significantly low DAO activity and high histamine levels compared to the experiment’s healthy people. The authors have cautiously indicated a possible correlation between decreased DAO activity in allergic patients.⁵⁵


Histamine receptors involved in atopic dermatitis

Histamine receptors belong to the family of GPCRs with seven transmembrane domains and an intracellular second messenger system to transduce extracellular signals through the TRPV1 channel.¹⁶⁵⁶ Since the beginning of the twentieth century, the synthesis of various histamine receptor antagonists has played a therapeutic role in treating a wide variety of diseases like AD, asthma, pruritus, allergic rhinitis, and inflammation.⁵⁷⁶⁰

However, antihistamine drugs’ failure to block histamine’s complete action initiated a research program that started at the laboratory of SmithKline and French in Welwyn Garden City, U.K. (1960), under the direction of James Black. He intended to confirm heterogeneity in histamine receptors (HRs) and discover an antagonist of the histamine receptor. HRs stay in equilibrium in relation to their active and inactive states.⁶¹

Various techniques, including immunohistochemistry, flow cytometry, and western blots, are generally used to analyze HRs.⁶² H1, H2, and H4 receptors are involved in chronic allergic contact dermatitis (CACD) and related inflammatory processes.

atopic dermatitis.⁶³ The study shows that in ovalbumin-induced AD skin lesions, analyzed in H4R knockout mice, the results showed a significant reduction in the severity of skin lesions, reduced inflammatory cells, and lessened hyper-proliferation at the skin lesion site.²⁰ Previously, it was considered that either H1R or H4R is involved in skin inflammation. However, the use of H1R antagonists only shows limited improvement in skin inflammation.

It is now confirmed that co-administration of H1R and H4R antagonists ameliorated chronic allergic inflammation in ovalbumin-induced AD-like skin lesions in a mouse treated with H1R inverse agonist mepyramine or with H4R antagonist JNJ-39758979⁶⁴ and also the itch associated with AD. Conventional treatment with glucocorticoids leads to skin atrophy and has side effects. However, co-administration of H1R and H4R antagonists has an inhibitory effect equal to those of steroids in a chronic allergic dermatitis mouse model.

In summary, HRs play an essential role in alleviating AD but are often inefficient in treating itch associated with AD because of the involvement of histamine-independent pathways. With this finding, next-generation antihistaminic agents using H1R and H4R antagonistic actions can be useful in developing treatments for AD patients.⁶⁵


Neural Pathways for Itch

One of the common symptoms in AD is itch, and various endogenous mediators have been identified as primary triggers that can cause itch.⁶⁶ Itch has been classified into four main clinical categories based on pathophysiological, anatomical, and psychological components and is further named neurogenic, pruritogenic, neuropathic, and psychogenic.⁶⁷

This section will discuss relevant literature that has been proposed to identify neural mechanisms of itch associated with AD. A labeled-line theory suggests that the itch-specific neuronal fibers are in the continuum from the skin to the dorsal root ganglia (DRG).⁷ Itch is classified into two major subtypes based on histaminergic and non-histaminergic pathways.

The histaminergic pathway is dependent upon the TRPV1-positive (via histamine or endothelin-1) and TRPV1-negative (via histamine) nerve fibers.¹⁶¹⁷⁶⁸⁶⁹

The non-histaminergic pathway usually involves pruritogens other than histamine (protease-activated receptor agonists, cysteine protease, and serotonin), and their effects are mediated through TRPA1 channels.⁷⁰⁷³ Once the sensory neurons are activated or depolarized, they release neurotransmitters/neuropeptides through the central afferents of the DRG into the spinal cord. The message is further propagated through interneurons that express natriuretic polypeptide receptor A (NPRA) in the spinal cord through projection neurons that express gastrin-releasing peptide receptor (GRPR) for the chemical-induced itch to the brain.⁷⁴ The brain finally decodes these messages in the somatosensory cortex.⁷⁵

A pruritogen is a mediator that provokes the sensation of itch in the skin, followed by interaction with molecular detectors. The majority of these molecular detectors are either pruritic receptors (generally G-protein coupled receptors—GPCR) or ion channel receptors (TRPV1, TRPV3, and TRPA1) that act downstream of GPCR to activate sensory neurons involved in the propagation of itch.²⁰⁷⁶⁸⁰

Histamine-mediated itch happens through HR. The four histamine GPCRs include H1, H2, H3, and H4 receptors. The H1 and H4 receptors convey itch neurotransmission directly through DRG sensory neurons via the TRPV1 channel.¹⁶¹⁷

In conclusion, we propose an increase in plasma histamine levels due to a histamine-enriched diet is linked with AD, but antihistamines remain ineffective in alleviating itch in AD individuals, except for a few.⁷⁵ The ineffectiveness of antihistamines is possibly explained by the involvement of other non-histaminergic itch pathways at the periphery or possibly through central mechanisms.

Some of the practical clinical, diagnostic, and therapeutic considerations suggested for individuals with atopic dermatitis include dietary recommendations with low histamine and identifying and avoiding trigger foods high in histamine, including fermented products, citrus fruits, alcohol, nuts, and certain types of fish. Diagnostic recommendations include measuring DAO activity in serum to diagnose histamine intolerance and manage AD symptoms effectively.

Lastly, for therapeutic options, considering L-histidine supplementation for atopic dermatitis management and including DAO supplements may alleviate symptoms in histamine-intolerant individuals.


Conclusion

Several reports suggest a link between food and atopic dermatitis, but the mechanistic insight into these relationships is still unclear. The role of dietary influence on the accumulation of high histamine in the body has been established and observed by showing that lowering histamine in the diet provides relief to a subgroup of AD patients.

Atopic dermatitis drastically affects a patient’s quality of life and can lead to several other diseases; therefore, it is imperative to understand the complex biological mechanisms in AD. Mechanisms of action behind food and their metabolites involved in AD pathogenesis and associated itch need to be identified, which might help develop better treatment methods.

More research needs to be done to establish a direct role of food in the pathogenesis of AD and itch.


Table 1. Gene polymorphisms that are linked to food allergy and AD

GeneSNPRelationshipReferences
DAOC2970GFood allergy⁴⁵
HNMT314C>T, 939A>GAD, Food additive, alcohol⁴⁶, ⁸¹, ⁴⁸


References

1. Avena-Woods C. Overview of atopic dermatitis. Am J Manag Care. Jun 2017;23(8 Suppl): S115-S123.

2. Odhiambo JA, Williams HC, Clayton TO, Robertson CF, Asher MI, Group IPTS. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol. Dec 2009;124(6):1251-8 e23.
doi:10.1016/j.jaci.2009.10.009

3. Eckert L, Gupta S, Amand C, Gadkari A, Mahajan P, Gelfand JM. The burden of atopic dermatitis in US adults: Health care resource utilization data from the 2013 National Health and Wellness Survey. J Am Acad Dermatol. Jan 2018; 78(1):54-61 e1. doi:10.1016/j.jaad.2017.08.002

4. Lerner EA. Is the Nervous System More Important Than the Immune System in Itch and Atopic Dermatitis? J Investig Dermatol Symp Proc. Dec 2018;19(2):S94. doi:10.1016/j.jisp.2018.10.002

5. Chung BY, Cho SI, Ahn IS, et al. Treatment of Atopic Dermatitis with a Low-histamine Diet. Ann Dermatol. Sep 2011;23 Suppl 1:S91-5. doi:10.5021/ad.2011.23.S1.S91

6. Worm M, Fiedler EM, Dolle S, et al. Exogenous histamine aggravates eczema in a subgroup of patients with atopic dermatitis. Acta Derm Venereol. 2009;89(1):52-6. doi:10.2340/00015555-0565

7. Uenishi T, Sugiura H, Tanaka T, Uehara M. Aggravation of atopic dermatitis in breast-fed infants by tree nut-related foods and fermented foods in breast milk. J Dermatol. Feb 2011;38 (2):140-5. doi:10.1111/j.1346-8138.2010.00968.x

8. Wang Z, Zhang LJ, Guha G, et al. Selective ablation of Ctip2/Bcl11b in epidermal keratinocytes triggers atopic dermatitis-like skin inflammatory responses in adult mice. PLoS One. 2012;7(12) :e51262. doi:10.1371/journal.pone.0051262

9. Mishra SK, Hoon MA. The cells and circuitry for itch responses in mice. Science. May 24 2013; 340(6135):968-71. doi:10.1126/science.1233765

10. Bath-Hextall F, Delamere FM, Williams HC. Dietary exclusions for established atopic eczema. Cochrane Database Syst Rev. Jan 23 2008;2008(1): CD005203. doi:10.1002/14651858.CD005203.pub2

11. Amon U, Menz U, Wolff HH. Investigations on plasma levels of mast cell mediators in acute atopic dermatitis. J Dermatol Sci. Feb 1994;7(1):63-7. doi:10.1016/0923-1811(94)90023-x

12. Nemeth K, Wilson T, Rada B, et al. Characterization and function of histamine receptors in human bone marrow stromal cells. Stem Cells. Feb 2012;30(2):222-31. doi:10.1002/stem.771

13. Parsons ME, Ganellin CR. Histamine and its receptors. Br J Pharmacol. Jan 2006;147 Suppl 1:S127-35. doi:10.1038/sj.bjp.0706440

14. Xie H, He SH. Roles of histamine and its receptors in allergic and inflammatory bowel diseases. World J Gastroenterol. May 21 2005;11 (19):2851-7. doi:10.3748/wjg.v11.i19.2851

15. Wantke F, Gotz M, Jarisch R. [The histamine-free diet]. Hautarzt. Aug 1993;44(8):512-6. Die histaminfreie Diat.

16. Kajihara Y, Murakami M, Imagawa T, Otsuguro K, Ito S, Ohta T. Histamine potentiates acid-induced responses mediating transient receptor potential V1 in mouse primary sensory neurons. Neuroscience. Mar 10 2010;166(1):292-304. doi:10.1016/j.neuroscience.2009.12.001

17. Kim BM, Lee SH, Shim WS, Oh U. Histamine-induced Ca(2+) influx via the PLA(2)/lipoxygenase/ TRPV1 pathway in rat sensory neurons. Neurosci Lett. May 6 2004;361(1-3):159-62. doi:10.1016/j.neulet.2004.01.019

18. Behrendt H, Ring J. Histamine, antihistamines and atopic eczema. Clin Exp Allergy. Nov 1990;20 Suppl 4:25-30. doi:10.1111/j.1365-2222.1990.tb0 2473.x

19. Mohajeri S, Newman SA. Review of evidence for dietary influences on atopic dermatitis. Skin Therapy Lett. Jul-Aug 2014;19(4):5-7.

20. Rossbach K, Schaper K, Kloth C, et al. Histamine H4 receptor knockout mice display reduced inflammation in a chronic model of atopic dermatitis. Allergy. Feb 2016;71(2):189-97.
doi:10.1111/all.12779

21. Sampson HA, Jolie PL. Increased plasma histamine concentrations after food challenges in children with atopic dermatitis. N Engl J Med. Aug 9 1984;311(6):372-6. doi:10.1056/NEJM198408093110605

22. De Benedetto A, Yoshida T, Fridy S, Park JE, Kuo IH, Beck LA. Histamine and Skin Barrier: Are Histamine Antagonists Useful for the Prevention or Treatment of Atopic Dermatitis? J Clin Med. Apr 21 2015;4(4):741-55. doi:10.3390/jcm4040741

23. Son JH, Chung BY, Kim HO, Park CW. A Histamine-Free Diet Is Helpful for Treatment of Adult Patients with Chronic Spontaneous Urticaria. Ann Dermatol. Apr 2018;30(2):164-172. doi:10.5021/ad.2018.30.2.164

24. Guida B, De Martino CD, De Martino SD, et al. Histamine plasma levels and elimination diet in chronic idiopathic urticaria. Eur J Clin Nutr. Feb 2000;54(2):155-8. doi:10.1038/sj.ejcn.1600911

25. Matterne U, Bohmer MM, Weisshaar E, Jupiter A, Carter B, Apfelbacher CJ. Oral H1 antihistamines as ‘add-on’ therapy to topical treatment for eczema. Cochrane Database Syst Rev. Jan 22 2019;1(1):CD012167.
doi:10.1002/14651858.CD012167.pub2

26. Chung BY, Cho SI, Ahn IS, et al. Treatment of Atopic Dermatitis with a Low-histamine Diet. Ann Dermatol. Sep 2011;23 Suppl 1(Suppl 1):S91-5. doi:10.5021/ad.2011.23.S1.S91

27. Rosell-Camps A, Zibetti S, Perez-Esteban G, Vila-Vidal M, Ferres-Ramis L, Garcia-Teresa-Garcia E. Histamine intolerance as a cause of chronic digestive complaints in pediatric patients. Rev Esp Enferm Dig. Apr 2013;105(4):201-6. doi:10.4321/s1130-01082013000400004

28. Schwelberger HG. Histamine intolerance: a metabolic disease? Inflamm Res. Mar 2010;59 Suppl 2:S219-21. doi:10.1007/s00011-009-0134-3

29. Lucas PM, Claisse O, Lonvaud-Funel A. High frequency of histamine-producing bacteria in the enological environment and instability of the histidine decarboxylase production phenotype. Appl Environ Microbiol. Feb 2008;74(3):811-7. doi:10.1128/AEM.01496-07

30. Toro-Funes N, Bosch-Fuste J, Latorre-Moratalla ML, Veciana-Nogues MT, Vidal-Carou MC. Biologically active amines in fermented and non-fermented commercial soybean products from the Spanish market. Food Chem. Apr 15 2015;173: 1119-24. doi:10.1016/j.foodchem.2014.10.118

31. Jantschitsch C, Kinaciyan T, Manafi M, Safer M, Tanew A. Severe scombroid fish poisoning: an underrecognized dermatologic emergency. J Am Acad Dermatol. Jul 2011;65(1):246-7.
doi:10.1016/j.jaad.2009.12.058

32. Morrow JD, Margolies GR, Rowland J, Roberts LJ, 2nd. Evidence that histamine is the causative toxin of scombroid-fish poisoning. N Engl J Med. Mar 14 1991;324(11):716-20. doi:10.1056/NEJM199103143241102

33. Hoffmann KM, Gruber E, Deutschmann A, Jahnel J, Hauer AC. Histamine intolerance in children with chronic abdominal pain. Arch Dis Child. Oct 2013;98(10):832-3. doi:10.1136/archdischild-2013-305024

34. Kofler L, Ulmer H, Kofler H. Histamine 50-skin-prick test: a tool to diagnose histamine intolerance. ISRN Allergy. 2011;2011:353045. doi:10.5402/2011/353045

35. Kovacova-Hanuskova E, Buday T, Gavliakova S, Plevkova J. Histamine, histamine intoxication and intolerance. Allergol Immunopathol (Madr). Sep-Oct 2015;43(5):498-506. doi:10.1016/j.aller.2015.05.001

36. Maintz L, Novak N. Histamine and histamine intolerance. Am J Clin Nutr. May 2007;85(5):1185-96. doi:10.1093/ajcn/85.5.1185

37. Zopf Y, Baenkler HW, Silbermann A, Hahn EG, Raithel M. The differential diagnosis of food intolerance. Dtsch Arztebl Int. May 2009;106(21): 359-69; quiz 369-70; 4 p following 370. doi:10.3238/arztebl.2009.0359

38. Chin KW, Garriga MM, Metcalfe DD. The histamine content of oriental foods. Food Chem Toxicol. May 1989;27(5):283-7. doi:10.1016/0278-6915(89)90129-4

39. Tan SP, Brown SB, Griffiths CE, Weller RB, Gibbs NK. Feeding filaggrin: effects of l-histidine supplementation in atopic dermatitis. Clin Cosmet Investig Dermatol. 2017;10:403-411. doi:10.2147/CCID.S146760

40. Holecek M. Histidine in Health and Disease: Metabolism, Physiological Importance, and Use as a Supplement. Nutrients. Mar 22 2020;12(3) doi:10.3390/nu12030848

41. Manzotti G, Breda D, Di Gioacchino M, Burastero SE. Serum diamine oxidase activity in patients with histamine intolerance. Int J Immunopathol Pharmacol. Mar 2016;29(1):105-11. doi:10.1177/0394632015617170

42. Lugovic-Mihic L, Seserko A, Duvancic T, Situm M, Mihic J. [Histamine intolerance–possible dermatologic sequences]. Acta Med Croatica. Dec 2012;66(5):375-81. Intolerancija na histamin–koje su moguce posljedice na kozi?

43. Petersen J, Drasche A, Raithel M, Schwelberger HG. Analysis of genetic polymorphisms of enzymes involved in histamine metabolism. Inflamm Res. Apr 2003;52 Suppl 1:S69-70. doi:10.1007/s000110300059

44. Petersen J, Raithel M, Schwelberger HG. Histamine N-methyltransferase and diamine oxidase gene polymorphisms in patients with inflammatory and neoplastic intestinal diseases. Inflamm Res. Apr 2002;51 Suppl 1:S91-2. doi:10.1007/pl00022464

45. Petersen J, Raithel M, Schwelberger HG. Characterisation of functional polymorphisms of the human diamine oxidase gene. Inflamm Res. Apr 2005;54 Suppl 1:S58-9. doi:10.1007/s00011-004-0426-6

46. Lee HS, Kim SH, Kim KW, et al. Involvement of human histamine N-methyltransferase gene polymorphisms in susceptibility to atopic dermatitis in korean children. Allergy Asthma Immunol Res. Jan 2012;4(1):31-6. doi:10.4168/aair.2012.4.1.31

47. Oroszi G, Enoch MA, Chun J, Virkkunen M, Goldman D. Thr105Ile, a functional polymorphism of histamine N-methyltransferase, is associated with alcoholism in two independent populations. Alcohol Clin Exp Res. Mar 2005;29(3):303-9. doi:10.1097/01.alc.0000156128.28257.2e

48. Stevenson J, Sonuga-Barke E, McCann D, et al. The role of histamine degradation gene polymorphisms in moderating the effects of food additives on children’s ADHD symptoms. Am J Psychiatry. Sep 2010;167(9):1108-15. doi:10.1176/appi.ajp.2010.09101529

49. McGrath AP, Hilmer KM, Collyer CA, et al. Structure and inhibition of human diamine oxidase. Biochemistry. Oct 20 2009;48(41):9810-22. doi:10.1021/bi9014192

50. Mizuguchi H, Imamura I, Takemura M, Fukui H. Purification and characterization of diamine oxidase (histaminase) from rat small intestine. J Biochem. Sep 1994;116(3):631-5.
doi:10.1093/oxfordjournals.jbchem.a124572

51. Razali NN, Hashim NH, Leow ATC, Salleh AB. Conformational Design and Characterisation of a Truncated Diamine Oxidase from Arthrobacter globiformis. High Throughput. Aug 25 2018;7(3) doi:10.3390/ht7030021

52. Kiehl R, Ionescu G. [Histamine degrading enzymes in atopic eczema]. Z Hautkr. Dec 15 1989;64(12):1121-3. Histamin-Abbauende Enzyme bei Atopischem Ekzem.

53. Maintz L, Benfadal S, Allam JP, Hagemann T, Fimmers R, Novak N. Evidence for a reduced histamine degradation capacity in a subgroup of patients with atopic eczema. J Allergy Clin Immunol. May 2006;117(5):1106-12. doi:10.1016/j.jaci.2005.11.041

54. Leitner R, Zoernpfenning E, Missbichler A. Evaluation of the inhibitory effect of various drugs / active ingredients on the activity of human diamine oxidase in vitro. Clinical and Translational Allergy. 2014;4(S3)doi:10.1186/2045-7022-4-s3-p23

55. Wagner A, Buczylko K, Zielinska-Blizniewska H, Wagner W. Impaired resolution of wheals in the skin prick test and low diamine oxidase blood level in allergic patients. Postepy Dermatol Alergol. Oct 2019;36(5):538-543. doi:10.5114/ada.2019.89504

56. Lagerstrom MC, Schioth HB. Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat Rev Drug Discov. Apr 2008;7(4):339-57. doi:10.1038/nrd2518

57. Hirasawa N, Ohsawa Y, Katoh G, et al. Modification of the picryl chloride-induced allergic dermatitis model in mouse ear lobes by 12-O-tetradecanoylphorbol 13-acetate, and analysis of the role of histamine in the modified model. Int Arch Allergy Immunol. 2009;148(4):279-88. doi:10.1159/000170381

58. Cowden JM, Riley JP, Ma JY, Thurmond RL, Dunford PJ. Histamine H4 receptor antagonism diminishes existing airway inflammation and dysfunction via modulation of Th2 cytokines. Respir Res. Jun 24 2010;11:86. doi:10.1186/1465-9921-11-86

59. Takahashi Y, Kagawa Y, Izawa K, Ono R, Akagi M, Kamei C. Effect of histamine H4 receptor antagonist on allergic rhinitis in mice. Int Immunopharmacol. Jun 2009;9(6):734-8. doi:10.1016/j.intimp.2009.02.011

60. Cowden JM, Yu F, Banie H, et al. The histamine H4 receptor mediates inflammation and Th17 responses in preclinical models of arthritis. Ann Rheum Dis. Mar 2014;73(3):600-8. doi:10.1136/annrheumdis-2013-203832

61. Jutel M, Watanabe T, Akdis M, Blaser K, Akdis CA. Immune regulation by histamine. Curr Opin Immunol. Dec 2002;14(6):735-40. doi:10.1016/s0952-7915(02)00395-3

62. Seifert R, Strasser A, Schneider EH, Neumann D, Dove S, Buschauer A. Molecular and cellular analysis of human histamine receptor subtypes. Trends Pharmacol Sci. Jan 2013;34(1):33-58. doi:10.1016/j.tips.2012.11.001

63. Ohtsu H, Seike M. Histamine and Histamine Receptors in Allergic Dermatitis. Handb Exp Pharmacol. 2017;241:333-345. doi:10.1007/164_2016_9

64. Kochling H, Schaper K, Wilzopolski J, et al. Combined treatment with H1 and H4 receptor antagonists reduces inflammation in a mouse model of atopic dermatitis. J Dermatol Sci. Aug 2017;87 (2):130-137. doi:10.1016/j.jdermsci.2017.04.004

65. Ohsawa Y, Hirasawa N. The antagonism of histamine H1 and H4 receptors ameliorates chronic allergic dermatitis via anti-pruritic and anti-inflammatory effects in NC/Nga mice. Allergy. Aug 2012;67(8):1014-22.
doi:10.1111/j.1398-9995.2012.02854.x

66. Mollanazar NK, Smith PK, Yosipovitch G. Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out? Clin Rev Allergy Immunol. Dec 2016;51(3):263-292. doi:10.1007/s12016-015-8488-5

67. Garibyan L, Rheingold CG, Lerner EA. Understanding the pathophysiology of itch. Dermatol Ther. Mar-Apr 2013;26(2):84-91. doi:10.1111/dth.12025

68. Nicolson TA, Bevan S, Richards CD. Characterisation of the calcium responses to histamine in capsaicin-sensitive and capsaicin-insensitive sensory neurones. Neuroscience. 2002;110(2):329-38.
doi:10.1016/s0306-4522(01)00561-9

69. Shim WS, Tak MH, Lee MH, et al. TRPV1 mediates histamine-induced itching via the activation of phospholipase A2 and 12-lipoxygenase. J Neurosci. Feb 28 2007;27(9):2331-7.
doi:10.1523/JNEUROSCI.4643-06.2007

70. Morita T, McClain SP, Batia LM, et al. HTR7 Mediates Serotonergic Acute and Chronic Itch. Neuron. Jul 1 2015;87(1):124-38. doi:10.1016/j.neuron.2015.05.044

71. Akiyama T, Merrill AW, Zanotto K, Carstens MI, Carstens E. Scratching behavior and Fos expression in superficial dorsal horn elicited by protease-activated receptor agonists and other itch mediators in mice. J Pharmacol Exp Ther. Jun 2009;329(3):945-51. doi:10.1124/jpet.109.152256

72. Steinhoff M, Neisius U, Ikoma A, et al. Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. J Neurosci. Jul 16 2003;23(15):6176-80.

73. Weisshaar E, Ziethen B, Gollnick H. Can a serotonin type 3 (5-HT3) receptor antagonist reduce experimentally-induced itch? Inflamm Res. Oct 1997;46(10):412-6. doi:10.1007/s000110050213

74. Sun YG, Chen ZF. A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord. Nature. Aug 9 2007;448(7154):700-U10. doi:10.1038/nature06029

75. Leknes SG, Bantick S, Willis CM, Wilkinson JD, Wise RG, Tracey I. Itch and motivation to scratch: an investigation of the central and peripheral correlates of allergen- and histamine-induced itch in humans. J Neurophysiol. Jan 2007;97(1):415-22. doi:10.1152/jn.00070.2006

76. Liu Q, Tang Z, Surdenikova L, et al. Sensory neuron-specific GPCR Mrgprs are itch receptors mediating chloroquine-induced pruritus. Cell. Dec 24 2009;139(7):1353-65. doi:10.1016/j.cell.2009.11.034

77. Imamachi N, Park GH, Lee H, et al. TRPV1-expressing primary afferents generate behavioral responses to pruritogens via multiple mechanisms. Proc Natl Acad Sci U S A. Jul 7 2009;106(27): 11330-5. doi:10.1073/pnas.0905605106

78. Han SK, Mancino V, Simon MI. Phospholipase Cbeta 3 mediates the scratching response activated by the histamine H1 receptor on C-fiber nociceptive neurons. Neuron. Nov 22 2006;52(4):691-703. doi:10.1016/j.neuron.2006.09.036

79. Cui TT, Wang GX, Wei NN, Wang K. A pivotal role for the activation of TRPV3 channel in itch sensations induced by the natural skin sensitizer carvacrol. Acta Pharmacol Sin. Mar 2018;39(3):331-335. doi:10.1038/aps.2017.152

80. Han L, Dong X. Itch mechanisms and circuits. Annu Rev Biophys. 2014;43:331-55.
doi:10.1146/annurev-biophys-051013-022826

81. Kennedy MJ, Loehle JA, Griffin AR, et al. Association of the histamine N-methyltransferase C314T (Thr105Ile) polymorphism with atopic dermatitis in Caucasian children. Pharmacotherapy. Dec 2008;28(12):1495-501.
doi:10.1592/phco.28.12.1495
Interested in publishing your own research?
ESMED members can publish their research for free in our peer-reviewed journal.
Learn About Membership

Call for papers

Have a manuscript to publish in the society's journal?